Trial Profile
The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial (AVEC Trial).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Hydrochlorothiazide (Primary) ; Lisinopril (Primary) ; Metoprolol; Nifedipine
- Indications Cognition disorders; Essential hypertension
- Focus Pharmacodynamics
- Acronyms AVEC
- 14 Feb 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2012 Results published in the Archives of Internal Medicine.